-
-
-
-
-
-
-
aTyr Pharma, Inc. (ATYR) Misses Q3 EPS by 9c
-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades aTyr Pharma (ATYR) to Neutral
-
-
-
-
-
-
-
aTyr Pharma (ATYR) September 3 puts active as share price down 8.2%
-
-
-
-
-
-
-
aTyr Pharma, Inc. (ATYR) Tops Q1 EPS by 2c
-
-
-
-
-
-
-
aTyr Pharma, Inc. (ATYR) Tops Q4 EPS by 5c
-
-
-
-
-
-
-
aTyr Pharma (ATYR) Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT Study in Pulmonary Sarcoidosis
-
-
-
-
-
-
-
Wells Fargo Starts aTyr Pharma (ATYR) at Overweight
-
456,879 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

